nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—CYP2D6—Temsirolimus—kidney cancer	0.17	0.372	CbGbCtD
Midodrine—CYP2D6—Pazopanib—kidney cancer	0.0894	0.195	CbGbCtD
Midodrine—CYP2D6—Erlotinib—kidney cancer	0.0638	0.139	CbGbCtD
Midodrine—CYP2D6—Sorafenib—kidney cancer	0.0519	0.113	CbGbCtD
Midodrine—CYP2D6—Vinblastine—kidney cancer	0.0512	0.112	CbGbCtD
Midodrine—CYP2D6—Doxorubicin—kidney cancer	0.0315	0.0687	CbGbCtD
Midodrine—Gastrointestinal disorder—Everolimus—kidney cancer	0.0011	0.00203	CcSEcCtD
Midodrine—Dyspnoea—Erlotinib—kidney cancer	0.0011	0.00202	CcSEcCtD
Midodrine—Dry skin—Capecitabine—kidney cancer	0.0011	0.00202	CcSEcCtD
Midodrine—Pain—Vinblastine—kidney cancer	0.00109	0.00202	CcSEcCtD
Midodrine—Stomatitis—Paclitaxel—kidney cancer	0.00109	0.00202	CcSEcCtD
Midodrine—Angiopathy—Gemcitabine—kidney cancer	0.00109	0.00201	CcSEcCtD
Midodrine—Pain—Everolimus—kidney cancer	0.00109	0.00201	CcSEcCtD
Midodrine—Dry mouth—Sunitinib—kidney cancer	0.00109	0.002	CcSEcCtD
Midodrine—Nervous system disorder—Sorafenib—kidney cancer	0.00109	0.002	CcSEcCtD
Midodrine—Dyspepsia—Erlotinib—kidney cancer	0.00108	0.002	CcSEcCtD
Midodrine—Rash—Temsirolimus—kidney cancer	0.00108	0.00199	CcSEcCtD
Midodrine—Dermatitis—Temsirolimus—kidney cancer	0.00108	0.00199	CcSEcCtD
Midodrine—Chills—Gemcitabine—kidney cancer	0.00108	0.00199	CcSEcCtD
Midodrine—Skin disorder—Sorafenib—kidney cancer	0.00108	0.00198	CcSEcCtD
Midodrine—Headache—Temsirolimus—kidney cancer	0.00107	0.00198	CcSEcCtD
Midodrine—Dizziness—Pazopanib—kidney cancer	0.00107	0.00197	CcSEcCtD
Midodrine—Back pain—Vincristine—kidney cancer	0.00107	0.00197	CcSEcCtD
Midodrine—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00106	0.00196	CcSEcCtD
Midodrine—Hepatobiliary disease—Paclitaxel—kidney cancer	0.00106	0.00196	CcSEcCtD
Midodrine—Feeling abnormal—Vinblastine—kidney cancer	0.00105	0.00195	CcSEcCtD
Midodrine—Pain—Erlotinib—kidney cancer	0.00105	0.00194	CcSEcCtD
Midodrine—Feeling abnormal—Everolimus—kidney cancer	0.00105	0.00194	CcSEcCtD
Midodrine—Gastrointestinal pain—Vinblastine—kidney cancer	0.00105	0.00193	CcSEcCtD
Midodrine—Nervous system disorder—Sunitinib—kidney cancer	0.00104	0.00193	CcSEcCtD
Midodrine—Gastrointestinal pain—Everolimus—kidney cancer	0.00104	0.00192	CcSEcCtD
Midodrine—Skin disorder—Sunitinib—kidney cancer	0.00103	0.00191	CcSEcCtD
Midodrine—Bradycardia—Paclitaxel—kidney cancer	0.00103	0.00189	CcSEcCtD
Midodrine—Rash—Pazopanib—kidney cancer	0.00102	0.00188	CcSEcCtD
Midodrine—Nausea—Temsirolimus—kidney cancer	0.00102	0.00188	CcSEcCtD
Midodrine—Dermatitis—Pazopanib—kidney cancer	0.00102	0.00188	CcSEcCtD
Midodrine—Agitation—Vincristine—kidney cancer	0.00101	0.00187	CcSEcCtD
Midodrine—Back pain—Gemcitabine—kidney cancer	0.00101	0.00187	CcSEcCtD
Midodrine—Abdominal pain—Vinblastine—kidney cancer	0.00101	0.00187	CcSEcCtD
Midodrine—Headache—Pazopanib—kidney cancer	0.00101	0.00187	CcSEcCtD
Midodrine—Abdominal pain—Everolimus—kidney cancer	0.00101	0.00186	CcSEcCtD
Midodrine—Gastrointestinal pain—Erlotinib—kidney cancer	0.00101	0.00186	CcSEcCtD
Midodrine—Urinary tract disorder—Paclitaxel—kidney cancer	0.000995	0.00183	CcSEcCtD
Midodrine—Abdominal discomfort—Capecitabine—kidney cancer	0.00099	0.00183	CcSEcCtD
Midodrine—Urethral disorder—Paclitaxel—kidney cancer	0.000987	0.00182	CcSEcCtD
Midodrine—Dyspnoea—Sorafenib—kidney cancer	0.000987	0.00182	CcSEcCtD
Midodrine—Cramps of lower extremities—Doxorubicin—kidney cancer	0.000975	0.0018	CcSEcCtD
Midodrine—Dyspepsia—Sorafenib—kidney cancer	0.000974	0.0018	CcSEcCtD
Midodrine—Abdominal pain—Erlotinib—kidney cancer	0.000973	0.00179	CcSEcCtD
Midodrine—Dysuria—Capecitabine—kidney cancer	0.000966	0.00178	CcSEcCtD
Midodrine—Insomnia—Sunitinib—kidney cancer	0.000963	0.00178	CcSEcCtD
Midodrine—Nausea—Pazopanib—kidney cancer	0.000959	0.00177	CcSEcCtD
Midodrine—Paraesthesia—Sunitinib—kidney cancer	0.000956	0.00176	CcSEcCtD
Midodrine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000956	0.00176	CcSEcCtD
Midodrine—Hypertension—Vincristine—kidney cancer	0.000953	0.00176	CcSEcCtD
Midodrine—Erythema multiforme—Paclitaxel—kidney cancer	0.000952	0.00176	CcSEcCtD
Midodrine—Dyspnoea—Sunitinib—kidney cancer	0.00095	0.00175	CcSEcCtD
Midodrine—Pain—Sorafenib—kidney cancer	0.000947	0.00175	CcSEcCtD
Midodrine—Dyspepsia—Sunitinib—kidney cancer	0.000938	0.00173	CcSEcCtD
Midodrine—Cardiac disorder—Paclitaxel—kidney cancer	0.000935	0.00172	CcSEcCtD
Midodrine—Flushing—Paclitaxel—kidney cancer	0.000935	0.00172	CcSEcCtD
Midodrine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00092	0.0017	CcSEcCtD
Midodrine—Asthenia—Vinblastine—kidney cancer	0.000918	0.00169	CcSEcCtD
Midodrine—Asthenia—Everolimus—kidney cancer	0.000915	0.00169	CcSEcCtD
Midodrine—Angiopathy—Paclitaxel—kidney cancer	0.000914	0.00169	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000913	0.00168	CcSEcCtD
Midodrine—Pain—Sunitinib—kidney cancer	0.000911	0.00168	CcSEcCtD
Midodrine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000905	0.00167	CcSEcCtD
Midodrine—Hypertension—Gemcitabine—kidney cancer	0.000904	0.00167	CcSEcCtD
Midodrine—Chills—Paclitaxel—kidney cancer	0.000904	0.00167	CcSEcCtD
Midodrine—Pruritus—Everolimus—kidney cancer	0.000902	0.00166	CcSEcCtD
Midodrine—Stomatitis—Capecitabine—kidney cancer	0.000897	0.00166	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000885	0.00163	CcSEcCtD
Midodrine—Nervous system disorder—Vincristine—kidney cancer	0.000883	0.00163	CcSEcCtD
Midodrine—Asthenia—Erlotinib—kidney cancer	0.000883	0.00163	CcSEcCtD
Midodrine—Mental disorder—Paclitaxel—kidney cancer	0.000882	0.00163	CcSEcCtD
Midodrine—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000881	0.00163	CcSEcCtD
Midodrine—Abdominal pain—Sorafenib—kidney cancer	0.000875	0.00161	CcSEcCtD
Midodrine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000871	0.00161	CcSEcCtD
Midodrine—Hepatobiliary disease—Capecitabine—kidney cancer	0.000871	0.00161	CcSEcCtD
Midodrine—Pruritus—Erlotinib—kidney cancer	0.00087	0.00161	CcSEcCtD
Midodrine—Flatulence—Paclitaxel—kidney cancer	0.000864	0.00159	CcSEcCtD
Midodrine—Pain—Dactinomycin—kidney cancer	0.000862	0.00159	CcSEcCtD
Midodrine—Tension—Paclitaxel—kidney cancer	0.00086	0.00159	CcSEcCtD
Midodrine—Nervousness—Paclitaxel—kidney cancer	0.000852	0.00157	CcSEcCtD
Midodrine—Back pain—Paclitaxel—kidney cancer	0.000848	0.00156	CcSEcCtD
Midodrine—Dizziness—Vinblastine—kidney cancer	0.000846	0.00156	CcSEcCtD
Midodrine—Dizziness—Everolimus—kidney cancer	0.000843	0.00156	CcSEcCtD
Midodrine—Muscle spasms—Paclitaxel—kidney cancer	0.000843	0.00156	CcSEcCtD
Midodrine—Abdominal pain—Sunitinib—kidney cancer	0.000842	0.00155	CcSEcCtD
Midodrine—Bradycardia—Capecitabine—kidney cancer	0.000841	0.00155	CcSEcCtD
Midodrine—Nervous system disorder—Gemcitabine—kidney cancer	0.000838	0.00155	CcSEcCtD
Midodrine—Feeling abnormal—Dactinomycin—kidney cancer	0.000831	0.00153	CcSEcCtD
Midodrine—Skin disorder—Gemcitabine—kidney cancer	0.00083	0.00153	CcSEcCtD
Midodrine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000825	0.00152	CcSEcCtD
Midodrine—Urinary tract disorder—Capecitabine—kidney cancer	0.000816	0.00151	CcSEcCtD
Midodrine—Insomnia—Vincristine—kidney cancer	0.000815	0.0015	CcSEcCtD
Midodrine—Dizziness—Erlotinib—kidney cancer	0.000814	0.0015	CcSEcCtD
Midodrine—Urethral disorder—Capecitabine—kidney cancer	0.00081	0.00149	CcSEcCtD
Midodrine—Paraesthesia—Vincristine—kidney cancer	0.000809	0.00149	CcSEcCtD
Midodrine—Agitation—Paclitaxel—kidney cancer	0.000806	0.00149	CcSEcCtD
Midodrine—Rash—Everolimus—kidney cancer	0.000804	0.00148	CcSEcCtD
Midodrine—Dermatitis—Everolimus—kidney cancer	0.000803	0.00148	CcSEcCtD
Midodrine—Headache—Vinblastine—kidney cancer	0.000802	0.00148	CcSEcCtD
Midodrine—Headache—Everolimus—kidney cancer	0.000799	0.00147	CcSEcCtD
Midodrine—Abdominal pain—Dactinomycin—kidney cancer	0.000797	0.00147	CcSEcCtD
Midodrine—Asthenia—Sorafenib—kidney cancer	0.000794	0.00147	CcSEcCtD
Midodrine—Pruritus—Sorafenib—kidney cancer	0.000783	0.00144	CcSEcCtD
Midodrine—Erythema multiforme—Capecitabine—kidney cancer	0.000781	0.00144	CcSEcCtD
Midodrine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000778	0.00143	CcSEcCtD
Midodrine—Rash—Erlotinib—kidney cancer	0.000776	0.00143	CcSEcCtD
Midodrine—Dermatitis—Erlotinib—kidney cancer	0.000775	0.00143	CcSEcCtD
Midodrine—Insomnia—Gemcitabine—kidney cancer	0.000773	0.00143	CcSEcCtD
Midodrine—Headache—Erlotinib—kidney cancer	0.000771	0.00142	CcSEcCtD
Midodrine—Pain—Vincristine—kidney cancer	0.00077	0.00142	CcSEcCtD
Midodrine—Paraesthesia—Gemcitabine—kidney cancer	0.000767	0.00142	CcSEcCtD
Midodrine—Flushing—Capecitabine—kidney cancer	0.000767	0.00142	CcSEcCtD
Midodrine—Cardiac disorder—Capecitabine—kidney cancer	0.000767	0.00142	CcSEcCtD
Midodrine—Asthenia—Sunitinib—kidney cancer	0.000764	0.00141	CcSEcCtD
Midodrine—Dyspnoea—Gemcitabine—kidney cancer	0.000762	0.00141	CcSEcCtD
Midodrine—Nausea—Vinblastine—kidney cancer	0.00076	0.0014	CcSEcCtD
Midodrine—Somnolence—Gemcitabine—kidney cancer	0.00076	0.0014	CcSEcCtD
Midodrine—Nausea—Everolimus—kidney cancer	0.000757	0.0014	CcSEcCtD
Midodrine—Hypertension—Paclitaxel—kidney cancer	0.000757	0.0014	CcSEcCtD
Midodrine—Pruritus—Sunitinib—kidney cancer	0.000754	0.00139	CcSEcCtD
Midodrine—Angiopathy—Capecitabine—kidney cancer	0.00075	0.00138	CcSEcCtD
Midodrine—Anxiety—Paclitaxel—kidney cancer	0.000744	0.00137	CcSEcCtD
Midodrine—Chills—Capecitabine—kidney cancer	0.000742	0.00137	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000741	0.00137	CcSEcCtD
Midodrine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000738	0.00136	CcSEcCtD
Midodrine—Gastrointestinal pain—Vincristine—kidney cancer	0.000737	0.00136	CcSEcCtD
Midodrine—Dizziness—Sorafenib—kidney cancer	0.000732	0.00135	CcSEcCtD
Midodrine—Pain—Gemcitabine—kidney cancer	0.000731	0.00135	CcSEcCtD
Midodrine—Nausea—Erlotinib—kidney cancer	0.000731	0.00135	CcSEcCtD
Midodrine—Dry mouth—Paclitaxel—kidney cancer	0.00073	0.00135	CcSEcCtD
Midodrine—Mental disorder—Capecitabine—kidney cancer	0.000724	0.00134	CcSEcCtD
Midodrine—Asthenia—Dactinomycin—kidney cancer	0.000723	0.00133	CcSEcCtD
Midodrine—Confusional state—Paclitaxel—kidney cancer	0.000721	0.00133	CcSEcCtD
Midodrine—Abdominal pain—Vincristine—kidney cancer	0.000712	0.00131	CcSEcCtD
Midodrine—Flatulence—Capecitabine—kidney cancer	0.000709	0.00131	CcSEcCtD
Midodrine—Dry skin—Doxorubicin—kidney cancer	0.000706	0.0013	CcSEcCtD
Midodrine—Dizziness—Sunitinib—kidney cancer	0.000704	0.0013	CcSEcCtD
Midodrine—Feeling abnormal—Gemcitabine—kidney cancer	0.000704	0.0013	CcSEcCtD
Midodrine—Nervous system disorder—Paclitaxel—kidney cancer	0.000702	0.00129	CcSEcCtD
Midodrine—Tachycardia—Paclitaxel—kidney cancer	0.000698	0.00129	CcSEcCtD
Midodrine—Rash—Sorafenib—kidney cancer	0.000698	0.00129	CcSEcCtD
Midodrine—Dermatitis—Sorafenib—kidney cancer	0.000697	0.00129	CcSEcCtD
Midodrine—Back pain—Capecitabine—kidney cancer	0.000696	0.00128	CcSEcCtD
Midodrine—Skin disorder—Paclitaxel—kidney cancer	0.000695	0.00128	CcSEcCtD
Midodrine—Headache—Sorafenib—kidney cancer	0.000693	0.00128	CcSEcCtD
Midodrine—Muscle spasms—Capecitabine—kidney cancer	0.000692	0.00128	CcSEcCtD
Midodrine—Rash—Sunitinib—kidney cancer	0.000672	0.00124	CcSEcCtD
Midodrine—Dermatitis—Sunitinib—kidney cancer	0.000671	0.00124	CcSEcCtD
Midodrine—Headache—Sunitinib—kidney cancer	0.000667	0.00123	CcSEcCtD
Midodrine—Nausea—Sorafenib—kidney cancer	0.000657	0.00121	CcSEcCtD
Midodrine—Insomnia—Paclitaxel—kidney cancer	0.000647	0.00119	CcSEcCtD
Midodrine—Asthenia—Vincristine—kidney cancer	0.000646	0.00119	CcSEcCtD
Midodrine—Paraesthesia—Paclitaxel—kidney cancer	0.000643	0.00119	CcSEcCtD
Midodrine—Dyspnoea—Paclitaxel—kidney cancer	0.000638	0.00118	CcSEcCtD
Midodrine—Somnolence—Paclitaxel—kidney cancer	0.000636	0.00117	CcSEcCtD
Midodrine—Rash—Dactinomycin—kidney cancer	0.000636	0.00117	CcSEcCtD
Midodrine—Nausea—Sunitinib—kidney cancer	0.000633	0.00117	CcSEcCtD
Midodrine—Dyspepsia—Paclitaxel—kidney cancer	0.00063	0.00116	CcSEcCtD
Midodrine—Dysuria—Doxorubicin—kidney cancer	0.000622	0.00115	CcSEcCtD
Midodrine—Hypertension—Capecitabine—kidney cancer	0.000621	0.00115	CcSEcCtD
Midodrine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000618	0.00114	CcSEcCtD
Midodrine—Pollakiuria—Doxorubicin—kidney cancer	0.000615	0.00113	CcSEcCtD
Midodrine—Asthenia—Gemcitabine—kidney cancer	0.000613	0.00113	CcSEcCtD
Midodrine—Pain—Paclitaxel—kidney cancer	0.000612	0.00113	CcSEcCtD
Midodrine—Anxiety—Capecitabine—kidney cancer	0.00061	0.00113	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000608	0.00112	CcSEcCtD
Midodrine—Pruritus—Gemcitabine—kidney cancer	0.000605	0.00112	CcSEcCtD
Midodrine—Dry mouth—Capecitabine—kidney cancer	0.000599	0.00111	CcSEcCtD
Midodrine—Nausea—Dactinomycin—kidney cancer	0.000599	0.0011	CcSEcCtD
Midodrine—Dizziness—Vincristine—kidney cancer	0.000596	0.0011	CcSEcCtD
Midodrine—Confusional state—Capecitabine—kidney cancer	0.000592	0.00109	CcSEcCtD
Midodrine—Feeling abnormal—Paclitaxel—kidney cancer	0.00059	0.00109	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000588	0.00109	CcSEcCtD
Midodrine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000585	0.00108	CcSEcCtD
Midodrine—Stomatitis—Doxorubicin—kidney cancer	0.000578	0.00107	CcSEcCtD
Midodrine—Nervous system disorder—Capecitabine—kidney cancer	0.000576	0.00106	CcSEcCtD
Midodrine—Tachycardia—Capecitabine—kidney cancer	0.000573	0.00106	CcSEcCtD
Midodrine—Skin disorder—Capecitabine—kidney cancer	0.00057	0.00105	CcSEcCtD
Midodrine—Rash—Vincristine—kidney cancer	0.000568	0.00105	CcSEcCtD
Midodrine—Dermatitis—Vincristine—kidney cancer	0.000567	0.00105	CcSEcCtD
Midodrine—Abdominal pain—Paclitaxel—kidney cancer	0.000566	0.00104	CcSEcCtD
Midodrine—Headache—Vincristine—kidney cancer	0.000564	0.00104	CcSEcCtD
Midodrine—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000561	0.00104	CcSEcCtD
Midodrine—Bradycardia—Doxorubicin—kidney cancer	0.000542	0.001	CcSEcCtD
Midodrine—Rash—Gemcitabine—kidney cancer	0.000539	0.000994	CcSEcCtD
Midodrine—Dermatitis—Gemcitabine—kidney cancer	0.000538	0.000993	CcSEcCtD
Midodrine—Headache—Gemcitabine—kidney cancer	0.000535	0.000988	CcSEcCtD
Midodrine—Nausea—Vincristine—kidney cancer	0.000535	0.000987	CcSEcCtD
Midodrine—Insomnia—Capecitabine—kidney cancer	0.000531	0.00098	CcSEcCtD
Midodrine—Paraesthesia—Capecitabine—kidney cancer	0.000527	0.000973	CcSEcCtD
Midodrine—Urinary tract disorder—Doxorubicin—kidney cancer	0.000526	0.000971	CcSEcCtD
Midodrine—Dyspnoea—Capecitabine—kidney cancer	0.000524	0.000966	CcSEcCtD
Midodrine—Urethral disorder—Doxorubicin—kidney cancer	0.000522	0.000963	CcSEcCtD
Midodrine—Dyspepsia—Capecitabine—kidney cancer	0.000517	0.000954	CcSEcCtD
Midodrine—Asthenia—Paclitaxel—kidney cancer	0.000513	0.000947	CcSEcCtD
Midodrine—Nausea—Gemcitabine—kidney cancer	0.000508	0.000937	CcSEcCtD
Midodrine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000507	0.000935	CcSEcCtD
Midodrine—Pruritus—Paclitaxel—kidney cancer	0.000506	0.000934	CcSEcCtD
Midodrine—Erythema multiforme—Doxorubicin—kidney cancer	0.000504	0.000929	CcSEcCtD
Midodrine—Pain—Capecitabine—kidney cancer	0.000502	0.000926	CcSEcCtD
Midodrine—Flushing—Doxorubicin—kidney cancer	0.000494	0.000912	CcSEcCtD
Midodrine—Cardiac disorder—Doxorubicin—kidney cancer	0.000494	0.000912	CcSEcCtD
Midodrine—Feeling abnormal—Capecitabine—kidney cancer	0.000484	0.000893	CcSEcCtD
Midodrine—Angiopathy—Doxorubicin—kidney cancer	0.000483	0.000892	CcSEcCtD
Midodrine—Gastrointestinal pain—Capecitabine—kidney cancer	0.00048	0.000886	CcSEcCtD
Midodrine—Chills—Doxorubicin—kidney cancer	0.000478	0.000882	CcSEcCtD
Midodrine—Dizziness—Paclitaxel—kidney cancer	0.000473	0.000873	CcSEcCtD
Midodrine—Mental disorder—Doxorubicin—kidney cancer	0.000467	0.000861	CcSEcCtD
Midodrine—Abdominal pain—Capecitabine—kidney cancer	0.000464	0.000856	CcSEcCtD
Midodrine—Flatulence—Doxorubicin—kidney cancer	0.000457	0.000843	CcSEcCtD
Midodrine—Tension—Doxorubicin—kidney cancer	0.000455	0.00084	CcSEcCtD
Midodrine—Rash—Paclitaxel—kidney cancer	0.000451	0.000832	CcSEcCtD
Midodrine—Dermatitis—Paclitaxel—kidney cancer	0.000451	0.000832	CcSEcCtD
Midodrine—Nervousness—Doxorubicin—kidney cancer	0.00045	0.000831	CcSEcCtD
Midodrine—Back pain—Doxorubicin—kidney cancer	0.000449	0.000828	CcSEcCtD
Midodrine—Headache—Paclitaxel—kidney cancer	0.000448	0.000827	CcSEcCtD
Midodrine—Muscle spasms—Doxorubicin—kidney cancer	0.000446	0.000823	CcSEcCtD
Midodrine—Agitation—Doxorubicin—kidney cancer	0.000426	0.000786	CcSEcCtD
Midodrine—Nausea—Paclitaxel—kidney cancer	0.000425	0.000784	CcSEcCtD
Midodrine—Asthenia—Capecitabine—kidney cancer	0.000421	0.000777	CcSEcCtD
Midodrine—Pruritus—Capecitabine—kidney cancer	0.000415	0.000766	CcSEcCtD
Midodrine—Hypertension—Doxorubicin—kidney cancer	0.0004	0.000739	CcSEcCtD
Midodrine—Anxiety—Doxorubicin—kidney cancer	0.000393	0.000726	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000392	0.000723	CcSEcCtD
Midodrine—Dizziness—Capecitabine—kidney cancer	0.000388	0.000716	CcSEcCtD
Midodrine—Dry mouth—Doxorubicin—kidney cancer	0.000386	0.000712	CcSEcCtD
Midodrine—Confusional state—Doxorubicin—kidney cancer	0.000382	0.000704	CcSEcCtD
Midodrine—Nervous system disorder—Doxorubicin—kidney cancer	0.000371	0.000685	CcSEcCtD
Midodrine—Rash—Capecitabine—kidney cancer	0.00037	0.000683	CcSEcCtD
Midodrine—Dermatitis—Capecitabine—kidney cancer	0.00037	0.000682	CcSEcCtD
Midodrine—Tachycardia—Doxorubicin—kidney cancer	0.000369	0.000682	CcSEcCtD
Midodrine—Headache—Capecitabine—kidney cancer	0.000368	0.000679	CcSEcCtD
Midodrine—Skin disorder—Doxorubicin—kidney cancer	0.000368	0.000678	CcSEcCtD
Midodrine—Nausea—Capecitabine—kidney cancer	0.000349	0.000643	CcSEcCtD
Midodrine—Insomnia—Doxorubicin—kidney cancer	0.000342	0.000632	CcSEcCtD
Midodrine—Paraesthesia—Doxorubicin—kidney cancer	0.00034	0.000627	CcSEcCtD
Midodrine—Dyspnoea—Doxorubicin—kidney cancer	0.000337	0.000623	CcSEcCtD
Midodrine—Somnolence—Doxorubicin—kidney cancer	0.000336	0.000621	CcSEcCtD
Midodrine—Dyspepsia—Doxorubicin—kidney cancer	0.000333	0.000615	CcSEcCtD
Midodrine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000327	0.000603	CcSEcCtD
Midodrine—Pain—Doxorubicin—kidney cancer	0.000324	0.000597	CcSEcCtD
Midodrine—Feeling abnormal—Doxorubicin—kidney cancer	0.000312	0.000575	CcSEcCtD
Midodrine—Gastrointestinal pain—Doxorubicin—kidney cancer	0.00031	0.000571	CcSEcCtD
Midodrine—Abdominal pain—Doxorubicin—kidney cancer	0.000299	0.000552	CcSEcCtD
Midodrine—Asthenia—Doxorubicin—kidney cancer	0.000272	0.000501	CcSEcCtD
Midodrine—Pruritus—Doxorubicin—kidney cancer	0.000268	0.000494	CcSEcCtD
Midodrine—Dizziness—Doxorubicin—kidney cancer	0.00025	0.000462	CcSEcCtD
Midodrine—Rash—Doxorubicin—kidney cancer	0.000239	0.00044	CcSEcCtD
Midodrine—Dermatitis—Doxorubicin—kidney cancer	0.000238	0.00044	CcSEcCtD
Midodrine—Headache—Doxorubicin—kidney cancer	0.000237	0.000437	CcSEcCtD
Midodrine—Nausea—Doxorubicin—kidney cancer	0.000225	0.000415	CcSEcCtD
